Chemoinformaics analysis of 3-Phenylpropyl cyclohexanecarboxylate
| Molecular Weight | 246.35 | nRot | 5 |
| Heavy Atom Molecular Weight | 224.174 | nRig | 13 |
| Exact Molecular Weight | 246.162 | nRing | 2 |
| Solubility: LogS | -5.327 | nHRing | 0 |
| Solubility: LogP | 4.72 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 42.9934 |
| nHD | 0 | BPOL | 24.6746 |
| QED | 0.584 |
| Synth | 1.659 |
| Natural Product Likeliness | -0.326 |
| NR-PPAR-gamma | 0.027 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.055 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -4.665 |
| MDCK | 0.0000264 |
| BBB | 0.926 |
| PPB | 0.918358 |
| VDSS | 2.663 |
| FU | 0.0341503 |
| CYP1A2-inh | 0.927 |
| CYP1A2-sub | 0.421 |
| CYP2c19-inh | 0.878 |
| CYP2c19-sub | 0.065 |
| CYP2c9-inh | 0.79 |
| CYP2c9-sub | 0.26 |
| CYP2d6-inh | 0.168 |
| CYP2d6-sub | 0.142 |
| CYP3a4-inh | 0.378 |
| CYP3a4-sub | 0.277 |
| CL | 7.637 |
| T12 | 0.285 |
| hERG | 0.432 |
| Ames | 0.025 |
| ROA | 0.049 |
| SkinSen | 0.949 |
| Carcinogencity | 0.254 |
| EI | 0.935 |
| Respiratory | 0.419 |
| NR-Aromatase | 0.201 |
| Antiviral | Yes |
| Prediction | 0.750791 |